Health Catalyst (HCAT) Misses Q4 EPS by 2c

Health Catalyst (NASDAQ: HCAT) reported Q4 EPS of $0.08, $0.02 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $74.8 million versus the consensus estimate of $73.82 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Uber Is Said To Be In Advanced Talks On Delivery Hero Takeover - Bloomberg
• Citi opens 90-day upside catalyst watch on Full Truck Alliance
• Priority Commerce wins multi-year deal with Pittsburgh Steelers